Opinion

Most Recent

image: Opinion: Scientists Must Think Beyond Science

Opinion: Scientists Must Think Beyond Science

By | March 23, 2017

If we are to defend science, we must stand together with the other truth-tellers, including our non-scientist colleagues.

2 Comments

image: Opinion: On “The Impact Factor Fallacy”

Opinion: On “The Impact Factor Fallacy”

By , , and | March 21, 2017

Papers published in low-impact journals are not necessarily low-quality scientific contributions.

1 Comment

image: Opinion: After We March

Opinion: After We March

By | March 16, 2017

How to become—and stay—involved in science policy 

4 Comments

A species concept based on interacting nuclear and mitochondrial genes in bird species holds promise to more objectively define species.

4 Comments

image: Opinion: Welcome to SciComm

Opinion: Welcome to SciComm

By | March 9, 2017

New to science communication? Here’s how to get started.

0 Comments

image: Opinion: Canine Models for Alzheimer’s

Opinion: Canine Models for Alzheimer’s

By | March 1, 2017

For research on drugs to treat neurodegenerative diseases, dogs offer a better predictor of clinical outcomes. 

7 Comments

image: Opinion: Is a Clone Really Born at Age Zero?

Opinion: Is a Clone Really Born at Age Zero?

By | February 21, 2017

More lessons from Dolly the sheep

1 Comment

image: Opinion: Sometimes, Scientists Must March

Opinion: Sometimes, Scientists Must March

By , , and | February 13, 2017

Lessons learned from the “Death of Evidence” demonstration in Canada

9 Comments

image: Opinion: Should Scientists Engage in Activism?

Opinion: Should Scientists Engage in Activism?

By | February 7, 2017

Scientists who accept funding with the tacit agreement that they keep their mouths shut about the government are far more threatening to an independent academy than those who speak their minds.

12 Comments

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham